000 01160 a2200313 4500
005 20250514034213.0
264 0 _c20021217
008 200212s 0 0 eng d
022 _a1472-4472
040 _aNLM
_beng
_cNLM
100 1 _aJardemark, Kent
245 0 0 _aDopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.
_h[electronic resource]
260 _bCurrent opinion in investigational drugs (London, England : 2000)
_cJan 2002
300 _a101-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aBrain
_xdrug effects
650 0 4 _aDopamine Antagonists
_xchemistry
650 0 4 _aDopamine D2 Receptor Antagonists
650 0 4 _aHumans
650 0 4 _aReceptors, Dopamine D2
_xbiosynthesis
650 0 4 _aReceptors, Dopamine D3
650 0 4 _aReceptors, Dopamine D4
650 0 4 _aSchizophrenia
_xdrug therapy
700 1 _aWadenberg, Marie-Louise
700 1 _aGrillner, Pernilla
700 1 _aSvensson, Torgny H
773 0 _tCurrent opinion in investigational drugs (London, England : 2000)
_gvol. 3
_gno. 1
_gp. 101-5
999 _c11950177
_d11950177